Investor Excitement Builds As Lexaria (LEXX) Unveils New Research Venture
The start of a new clinical study has caused a notable spike in the stock price of Lexaria Bioscience Corp. (NASDAQ: LEXX), which increased by 32.54% to $4.48 in the most recent trading session. Details of an 8-week animal research named WEIGHT-A24-1 were released by LEXX yesterday. The study’s goal was to investigate the effects […]
